A series of novel quinolone-based small molecule inhibitors of inosine monophosphate dehydrogenase (IMPDH) was explored. The synthesis and the structure-activity relationships (SARs) derived from in vitro studies are described. (C) 2002 Elsevier Science Ltd. All rights reserved.
A series of novel quinolone-based small molecule inhibitors of inosine monophosphate dehydrogenase (IMPDH) was explored. The synthesis and the structure-activity relationships (SARs) derived from in vitro studies are described. (C) 2002 Elsevier Science Ltd. All rights reserved.
Compounds of the formula
1
wherein X
1
is C(O), —S(O)—, or —S(O)
2
—;
X
2
is CR
3
or N; X
3
is —NH—, —O—, or —S—;
X
4
is CR
4
or N; X
5
is CR
5
or N; and X
6
is CR
6
or N are useful as inhibitors of IMPDH enzyme. Thus, these compounds can be used as therapeutic agents for IMPDH-associated disorders.
作者:Scott H. Watterson、Marianne Carlsen、T.G. Murali Dhar、Zhongqi Shen、William J. Pitts、Junqing Guo、Henry H. Gu、Derek Norris、John Chorba、Ping Chen、Daniel Cheney、Mark Witmer、Catherine A. Fleener、Katherine Rouleau、Robert Townsend、Diane L. Hollenbaugh、Edwin J. Iwanowicz
DOI:10.1016/s0960-894x(02)00944-7
日期:2003.2
A series of novel quinolone-based small molecule inhibitors of inosine monophosphate dehydrogenase (IMPDH) was explored. The synthesis and the structure-activity relationships (SARs) derived from in vitro studies are described. (C) 2002 Elsevier Science Ltd. All rights reserved.